Global Psychoactive Substances Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Psychoactive Substances Industry Forecast” looks at past sales and reviews total world Psychoactive Substances sales in 2022, providing a comprehensive analysis by region and market sector of projected Psychoactive Substances sales for 2023 through 2029. With Psychoactive Substances sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psychoactive Substances industry.
This Insight Report provides a comprehensive analysis of the global Psychoactive Substances landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Psychoactive Substances portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psychoactive Substances market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psychoactive Substances and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psychoactive Substances.
The global Psychoactive Substances market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Psychoactive Substances is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Psychoactive Substances is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Psychoactive Substances is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Psychoactive Substances players cover Zynerba Pharmaceuticals, GW Pharmaceuticals PLC., Enecta., Teewinot Life Sciences, GD Pharma, Cape Bouvard Technologies Pty Ltd, AusCann Group Holdings Pty Ltd., Cannabics Pharmaceuticals Inc. and Alpha-CAT, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Psychoactive Substances market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Psychoactive Substances Industry Forecast” looks at past sales and reviews total world Psychoactive Substances sales in 2022, providing a comprehensive analysis by region and market sector of projected Psychoactive Substances sales for 2023 through 2029. With Psychoactive Substances sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psychoactive Substances industry.
This Insight Report provides a comprehensive analysis of the global Psychoactive Substances landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Psychoactive Substances portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psychoactive Substances market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psychoactive Substances and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psychoactive Substances.
The global Psychoactive Substances market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Psychoactive Substances is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Psychoactive Substances is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Psychoactive Substances is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Psychoactive Substances players cover Zynerba Pharmaceuticals, GW Pharmaceuticals PLC., Enecta., Teewinot Life Sciences, GD Pharma, Cape Bouvard Technologies Pty Ltd, AusCann Group Holdings Pty Ltd., Cannabics Pharmaceuticals Inc. and Alpha-CAT, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Psychoactive Substances market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Stimulants
- Cannabinoids
- Hallucinogens
- Depressants
- Cancer
- Neuropathic Disorders
- Spasticity
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zynerba Pharmaceuticals
- GW Pharmaceuticals PLC.
- Enecta.
- Teewinot Life Sciences
- GD Pharma
- Cape Bouvard Technologies Pty Ltd
- AusCann Group Holdings Pty Ltd.
- Cannabics Pharmaceuticals Inc.
- Alpha-CAT
- Tilray
- Cyrelian Pty Ltd.
- MedReleaf Australia
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psychoactive Substances Market Size 2018-2029
2.1.2 Psychoactive Substances Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Psychoactive Substances Segment by Type
2.2.1 Stimulants
2.2.2 Cannabinoids
2.2.3 Hallucinogens
2.2.4 Depressants
2.3 Psychoactive Substances Market Size by Type
2.3.1 Psychoactive Substances Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Psychoactive Substances Market Size Market Share by Type (2018-2023)
2.4 Psychoactive Substances Segment by Application
2.4.1 Cancer
2.4.2 Neuropathic Disorders
2.4.3 Spasticity
2.5 Psychoactive Substances Market Size by Application
2.5.1 Psychoactive Substances Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Psychoactive Substances Market Size Market Share by Application (2018-2023)
3 PSYCHOACTIVE SUBSTANCES MARKET SIZE BY PLAYER
3.1 Psychoactive Substances Market Size Market Share by Players
3.1.1 Global Psychoactive Substances Revenue by Players (2018-2023)
3.1.2 Global Psychoactive Substances Revenue Market Share by Players (2018-2023)
3.2 Global Psychoactive Substances Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSYCHOACTIVE SUBSTANCES BY REGIONS
4.1 Psychoactive Substances Market Size by Regions (2018-2023)
4.2 Americas Psychoactive Substances Market Size Growth (2018-2023)
4.3 APAC Psychoactive Substances Market Size Growth (2018-2023)
4.4 Europe Psychoactive Substances Market Size Growth (2018-2023)
4.5 Middle East & Africa Psychoactive Substances Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Psychoactive Substances Market Size by Country (2018-2023)
5.2 Americas Psychoactive Substances Market Size by Type (2018-2023)
5.3 Americas Psychoactive Substances Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psychoactive Substances Market Size by Region (2018-2023)
6.2 APAC Psychoactive Substances Market Size by Type (2018-2023)
6.3 APAC Psychoactive Substances Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psychoactive Substances by Country (2018-2023)
7.2 Europe Psychoactive Substances Market Size by Type (2018-2023)
7.3 Europe Psychoactive Substances Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psychoactive Substances by Region (2018-2023)
8.2 Middle East & Africa Psychoactive Substances Market Size by Type (2018-2023)
8.3 Middle East & Africa Psychoactive Substances Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSYCHOACTIVE SUBSTANCES MARKET FORECAST
10.1 Global Psychoactive Substances Forecast by Regions (2024-2029)
10.1.1 Global Psychoactive Substances Forecast by Regions (2024-2029)
10.1.2 Americas Psychoactive Substances Forecast
10.1.3 APAC Psychoactive Substances Forecast
10.1.4 Europe Psychoactive Substances Forecast
10.1.5 Middle East & Africa Psychoactive Substances Forecast
10.2 Americas Psychoactive Substances Forecast by Country (2024-2029)
10.2.1 United States Psychoactive Substances Market Forecast
10.2.2 Canada Psychoactive Substances Market Forecast
10.2.3 Mexico Psychoactive Substances Market Forecast
10.2.4 Brazil Psychoactive Substances Market Forecast
10.3 APAC Psychoactive Substances Forecast by Region (2024-2029)
10.3.1 China Psychoactive Substances Market Forecast
10.3.2 Japan Psychoactive Substances Market Forecast
10.3.3 Korea Psychoactive Substances Market Forecast
10.3.4 Southeast Asia Psychoactive Substances Market Forecast
10.3.5 India Psychoactive Substances Market Forecast
10.3.6 Australia Psychoactive Substances Market Forecast
10.4 Europe Psychoactive Substances Forecast by Country (2024-2029)
10.4.1 Germany Psychoactive Substances Market Forecast
10.4.2 France Psychoactive Substances Market Forecast
10.4.3 UK Psychoactive Substances Market Forecast
10.4.4 Italy Psychoactive Substances Market Forecast
10.4.5 Russia Psychoactive Substances Market Forecast
10.5 Middle East & Africa Psychoactive Substances Forecast by Region (2024-2029)
10.5.1 Egypt Psychoactive Substances Market Forecast
10.5.2 South Africa Psychoactive Substances Market Forecast
10.5.3 Israel Psychoactive Substances Market Forecast
10.5.4 Turkey Psychoactive Substances Market Forecast
10.5.5 GCC Countries Psychoactive Substances Market Forecast
10.6 Global Psychoactive Substances Forecast by Type (2024-2029)
10.7 Global Psychoactive Substances Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Information
11.1.2 Zynerba Pharmaceuticals Psychoactive Substances Product Offered
11.1.3 Zynerba Pharmaceuticals Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Zynerba Pharmaceuticals Main Business Overview
11.1.5 Zynerba Pharmaceuticals Latest Developments
11.2 GW Pharmaceuticals PLC.
11.2.1 GW Pharmaceuticals PLC. Company Information
11.2.2 GW Pharmaceuticals PLC. Psychoactive Substances Product Offered
11.2.3 GW Pharmaceuticals PLC. Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GW Pharmaceuticals PLC. Main Business Overview
11.2.5 GW Pharmaceuticals PLC. Latest Developments
11.3 Enecta.
11.3.1 Enecta. Company Information
11.3.2 Enecta. Psychoactive Substances Product Offered
11.3.3 Enecta. Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Enecta. Main Business Overview
11.3.5 Enecta. Latest Developments
11.4 Teewinot Life Sciences
11.4.1 Teewinot Life Sciences Company Information
11.4.2 Teewinot Life Sciences Psychoactive Substances Product Offered
11.4.3 Teewinot Life Sciences Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Teewinot Life Sciences Main Business Overview
11.4.5 Teewinot Life Sciences Latest Developments
11.5 GD Pharma
11.5.1 GD Pharma Company Information
11.5.2 GD Pharma Psychoactive Substances Product Offered
11.5.3 GD Pharma Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 GD Pharma Main Business Overview
11.5.5 GD Pharma Latest Developments
11.6 Cape Bouvard Technologies Pty Ltd
11.6.1 Cape Bouvard Technologies Pty Ltd Company Information
11.6.2 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Offered
11.6.3 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Cape Bouvard Technologies Pty Ltd Main Business Overview
11.6.5 Cape Bouvard Technologies Pty Ltd Latest Developments
11.7 AusCann Group Holdings Pty Ltd.
11.7.1 AusCann Group Holdings Pty Ltd. Company Information
11.7.2 AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Offered
11.7.3 AusCann Group Holdings Pty Ltd. Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 AusCann Group Holdings Pty Ltd. Main Business Overview
11.7.5 AusCann Group Holdings Pty Ltd. Latest Developments
11.8 Cannabics Pharmaceuticals Inc.
11.8.1 Cannabics Pharmaceuticals Inc. Company Information
11.8.2 Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Offered
11.8.3 Cannabics Pharmaceuticals Inc. Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Cannabics Pharmaceuticals Inc. Main Business Overview
11.8.5 Cannabics Pharmaceuticals Inc. Latest Developments
11.9 Alpha-CAT
11.9.1 Alpha-CAT Company Information
11.9.2 Alpha-CAT Psychoactive Substances Product Offered
11.9.3 Alpha-CAT Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Alpha-CAT Main Business Overview
11.9.5 Alpha-CAT Latest Developments
11.10 Tilray
11.10.1 Tilray Company Information
11.10.2 Tilray Psychoactive Substances Product Offered
11.10.3 Tilray Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Tilray Main Business Overview
11.10.5 Tilray Latest Developments
11.11 Cyrelian Pty Ltd.
11.11.1 Cyrelian Pty Ltd. Company Information
11.11.2 Cyrelian Pty Ltd. Psychoactive Substances Product Offered
11.11.3 Cyrelian Pty Ltd. Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cyrelian Pty Ltd. Main Business Overview
11.11.5 Cyrelian Pty Ltd. Latest Developments
11.12 MedReleaf Australia
11.12.1 MedReleaf Australia Company Information
11.12.2 MedReleaf Australia Psychoactive Substances Product Offered
11.12.3 MedReleaf Australia Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 MedReleaf Australia Main Business Overview
11.12.5 MedReleaf Australia Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psychoactive Substances Market Size 2018-2029
2.1.2 Psychoactive Substances Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Psychoactive Substances Segment by Type
2.2.1 Stimulants
2.2.2 Cannabinoids
2.2.3 Hallucinogens
2.2.4 Depressants
2.3 Psychoactive Substances Market Size by Type
2.3.1 Psychoactive Substances Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Psychoactive Substances Market Size Market Share by Type (2018-2023)
2.4 Psychoactive Substances Segment by Application
2.4.1 Cancer
2.4.2 Neuropathic Disorders
2.4.3 Spasticity
2.5 Psychoactive Substances Market Size by Application
2.5.1 Psychoactive Substances Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Psychoactive Substances Market Size Market Share by Application (2018-2023)
3 PSYCHOACTIVE SUBSTANCES MARKET SIZE BY PLAYER
3.1 Psychoactive Substances Market Size Market Share by Players
3.1.1 Global Psychoactive Substances Revenue by Players (2018-2023)
3.1.2 Global Psychoactive Substances Revenue Market Share by Players (2018-2023)
3.2 Global Psychoactive Substances Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSYCHOACTIVE SUBSTANCES BY REGIONS
4.1 Psychoactive Substances Market Size by Regions (2018-2023)
4.2 Americas Psychoactive Substances Market Size Growth (2018-2023)
4.3 APAC Psychoactive Substances Market Size Growth (2018-2023)
4.4 Europe Psychoactive Substances Market Size Growth (2018-2023)
4.5 Middle East & Africa Psychoactive Substances Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Psychoactive Substances Market Size by Country (2018-2023)
5.2 Americas Psychoactive Substances Market Size by Type (2018-2023)
5.3 Americas Psychoactive Substances Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psychoactive Substances Market Size by Region (2018-2023)
6.2 APAC Psychoactive Substances Market Size by Type (2018-2023)
6.3 APAC Psychoactive Substances Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psychoactive Substances by Country (2018-2023)
7.2 Europe Psychoactive Substances Market Size by Type (2018-2023)
7.3 Europe Psychoactive Substances Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psychoactive Substances by Region (2018-2023)
8.2 Middle East & Africa Psychoactive Substances Market Size by Type (2018-2023)
8.3 Middle East & Africa Psychoactive Substances Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSYCHOACTIVE SUBSTANCES MARKET FORECAST
10.1 Global Psychoactive Substances Forecast by Regions (2024-2029)
10.1.1 Global Psychoactive Substances Forecast by Regions (2024-2029)
10.1.2 Americas Psychoactive Substances Forecast
10.1.3 APAC Psychoactive Substances Forecast
10.1.4 Europe Psychoactive Substances Forecast
10.1.5 Middle East & Africa Psychoactive Substances Forecast
10.2 Americas Psychoactive Substances Forecast by Country (2024-2029)
10.2.1 United States Psychoactive Substances Market Forecast
10.2.2 Canada Psychoactive Substances Market Forecast
10.2.3 Mexico Psychoactive Substances Market Forecast
10.2.4 Brazil Psychoactive Substances Market Forecast
10.3 APAC Psychoactive Substances Forecast by Region (2024-2029)
10.3.1 China Psychoactive Substances Market Forecast
10.3.2 Japan Psychoactive Substances Market Forecast
10.3.3 Korea Psychoactive Substances Market Forecast
10.3.4 Southeast Asia Psychoactive Substances Market Forecast
10.3.5 India Psychoactive Substances Market Forecast
10.3.6 Australia Psychoactive Substances Market Forecast
10.4 Europe Psychoactive Substances Forecast by Country (2024-2029)
10.4.1 Germany Psychoactive Substances Market Forecast
10.4.2 France Psychoactive Substances Market Forecast
10.4.3 UK Psychoactive Substances Market Forecast
10.4.4 Italy Psychoactive Substances Market Forecast
10.4.5 Russia Psychoactive Substances Market Forecast
10.5 Middle East & Africa Psychoactive Substances Forecast by Region (2024-2029)
10.5.1 Egypt Psychoactive Substances Market Forecast
10.5.2 South Africa Psychoactive Substances Market Forecast
10.5.3 Israel Psychoactive Substances Market Forecast
10.5.4 Turkey Psychoactive Substances Market Forecast
10.5.5 GCC Countries Psychoactive Substances Market Forecast
10.6 Global Psychoactive Substances Forecast by Type (2024-2029)
10.7 Global Psychoactive Substances Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Information
11.1.2 Zynerba Pharmaceuticals Psychoactive Substances Product Offered
11.1.3 Zynerba Pharmaceuticals Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Zynerba Pharmaceuticals Main Business Overview
11.1.5 Zynerba Pharmaceuticals Latest Developments
11.2 GW Pharmaceuticals PLC.
11.2.1 GW Pharmaceuticals PLC. Company Information
11.2.2 GW Pharmaceuticals PLC. Psychoactive Substances Product Offered
11.2.3 GW Pharmaceuticals PLC. Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GW Pharmaceuticals PLC. Main Business Overview
11.2.5 GW Pharmaceuticals PLC. Latest Developments
11.3 Enecta.
11.3.1 Enecta. Company Information
11.3.2 Enecta. Psychoactive Substances Product Offered
11.3.3 Enecta. Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Enecta. Main Business Overview
11.3.5 Enecta. Latest Developments
11.4 Teewinot Life Sciences
11.4.1 Teewinot Life Sciences Company Information
11.4.2 Teewinot Life Sciences Psychoactive Substances Product Offered
11.4.3 Teewinot Life Sciences Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Teewinot Life Sciences Main Business Overview
11.4.5 Teewinot Life Sciences Latest Developments
11.5 GD Pharma
11.5.1 GD Pharma Company Information
11.5.2 GD Pharma Psychoactive Substances Product Offered
11.5.3 GD Pharma Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 GD Pharma Main Business Overview
11.5.5 GD Pharma Latest Developments
11.6 Cape Bouvard Technologies Pty Ltd
11.6.1 Cape Bouvard Technologies Pty Ltd Company Information
11.6.2 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Offered
11.6.3 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Cape Bouvard Technologies Pty Ltd Main Business Overview
11.6.5 Cape Bouvard Technologies Pty Ltd Latest Developments
11.7 AusCann Group Holdings Pty Ltd.
11.7.1 AusCann Group Holdings Pty Ltd. Company Information
11.7.2 AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Offered
11.7.3 AusCann Group Holdings Pty Ltd. Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 AusCann Group Holdings Pty Ltd. Main Business Overview
11.7.5 AusCann Group Holdings Pty Ltd. Latest Developments
11.8 Cannabics Pharmaceuticals Inc.
11.8.1 Cannabics Pharmaceuticals Inc. Company Information
11.8.2 Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Offered
11.8.3 Cannabics Pharmaceuticals Inc. Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Cannabics Pharmaceuticals Inc. Main Business Overview
11.8.5 Cannabics Pharmaceuticals Inc. Latest Developments
11.9 Alpha-CAT
11.9.1 Alpha-CAT Company Information
11.9.2 Alpha-CAT Psychoactive Substances Product Offered
11.9.3 Alpha-CAT Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Alpha-CAT Main Business Overview
11.9.5 Alpha-CAT Latest Developments
11.10 Tilray
11.10.1 Tilray Company Information
11.10.2 Tilray Psychoactive Substances Product Offered
11.10.3 Tilray Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Tilray Main Business Overview
11.10.5 Tilray Latest Developments
11.11 Cyrelian Pty Ltd.
11.11.1 Cyrelian Pty Ltd. Company Information
11.11.2 Cyrelian Pty Ltd. Psychoactive Substances Product Offered
11.11.3 Cyrelian Pty Ltd. Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cyrelian Pty Ltd. Main Business Overview
11.11.5 Cyrelian Pty Ltd. Latest Developments
11.12 MedReleaf Australia
11.12.1 MedReleaf Australia Company Information
11.12.2 MedReleaf Australia Psychoactive Substances Product Offered
11.12.3 MedReleaf Australia Psychoactive Substances Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 MedReleaf Australia Main Business Overview
11.12.5 MedReleaf Australia Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psychoactive Substances Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Stimulants
Table 3. Major Players of Cannabinoids
Table 4. Major Players of Hallucinogens
Table 5. Major Players of Depressants
Table 6. Psychoactive Substances Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Psychoactive Substances Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Psychoactive Substances Market Size Market Share by Type (2018-2023)
Table 9. Psychoactive Substances Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Psychoactive Substances Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Psychoactive Substances Market Size Market Share by Application (2018-2023)
Table 12. Global Psychoactive Substances Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Psychoactive Substances Revenue Market Share by Player (2018-2023)
Table 14. Psychoactive Substances Key Players Head office and Products Offered
Table 15. Psychoactive Substances Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Psychoactive Substances Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Psychoactive Substances Market Size Market Share by Regions (2018-2023)
Table 20. Global Psychoactive Substances Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Psychoactive Substances Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Psychoactive Substances Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Psychoactive Substances Market Size Market Share by Country (2018-2023)
Table 24. Americas Psychoactive Substances Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Psychoactive Substances Market Size Market Share by Type (2018-2023)
Table 26. Americas Psychoactive Substances Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Psychoactive Substances Market Size Market Share by Application (2018-2023)
Table 28. APAC Psychoactive Substances Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Psychoactive Substances Market Size Market Share by Region (2018-2023)
Table 30. APAC Psychoactive Substances Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Psychoactive Substances Market Size Market Share by Type (2018-2023)
Table 32. APAC Psychoactive Substances Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Psychoactive Substances Market Size Market Share by Application (2018-2023)
Table 34. Europe Psychoactive Substances Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Psychoactive Substances Market Size Market Share by Country (2018-2023)
Table 36. Europe Psychoactive Substances Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Psychoactive Substances Market Size Market Share by Type (2018-2023)
Table 38. Europe Psychoactive Substances Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Psychoactive Substances Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Psychoactive Substances Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Psychoactive Substances Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Psychoactive Substances Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Psychoactive Substances Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Psychoactive Substances Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Psychoactive Substances Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Psychoactive Substances
Table 47. Key Market Challenges & Risks of Psychoactive Substances
Table 48. Key Industry Trends of Psychoactive Substances
Table 49. Global Psychoactive Substances Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Psychoactive Substances Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Psychoactive Substances Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Psychoactive Substances Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Zynerba Pharmaceuticals Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 54. Zynerba Pharmaceuticals Psychoactive Substances Product Offered
Table 55. Zynerba Pharmaceuticals Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Zynerba Pharmaceuticals Main Business
Table 57. Zynerba Pharmaceuticals Latest Developments
Table 58. GW Pharmaceuticals PLC. Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 59. GW Pharmaceuticals PLC. Psychoactive Substances Product Offered
Table 60. GW Pharmaceuticals PLC. Main Business
Table 61. GW Pharmaceuticals PLC. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. GW Pharmaceuticals PLC. Latest Developments
Table 63. Enecta. Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 64. Enecta. Psychoactive Substances Product Offered
Table 65. Enecta. Main Business
Table 66. Enecta. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Enecta. Latest Developments
Table 68. Teewinot Life Sciences Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 69. Teewinot Life Sciences Psychoactive Substances Product Offered
Table 70. Teewinot Life Sciences Main Business
Table 71. Teewinot Life Sciences Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Teewinot Life Sciences Latest Developments
Table 73. GD Pharma Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 74. GD Pharma Psychoactive Substances Product Offered
Table 75. GD Pharma Main Business
Table 76. GD Pharma Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. GD Pharma Latest Developments
Table 78. Cape Bouvard Technologies Pty Ltd Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 79. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Offered
Table 80. Cape Bouvard Technologies Pty Ltd Main Business
Table 81. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Cape Bouvard Technologies Pty Ltd Latest Developments
Table 83. AusCann Group Holdings Pty Ltd. Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 84. AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Offered
Table 85. AusCann Group Holdings Pty Ltd. Main Business
Table 86. AusCann Group Holdings Pty Ltd. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. AusCann Group Holdings Pty Ltd. Latest Developments
Table 88. Cannabics Pharmaceuticals Inc. Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 89. Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Offered
Table 90. Cannabics Pharmaceuticals Inc. Main Business
Table 91. Cannabics Pharmaceuticals Inc. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Cannabics Pharmaceuticals Inc. Latest Developments
Table 93. Alpha-CAT Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 94. Alpha-CAT Psychoactive Substances Product Offered
Table 95. Alpha-CAT Main Business
Table 96. Alpha-CAT Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Alpha-CAT Latest Developments
Table 98. Tilray Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 99. Tilray Psychoactive Substances Product Offered
Table 100. Tilray Main Business
Table 101. Tilray Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Tilray Latest Developments
Table 103. Cyrelian Pty Ltd. Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 104. Cyrelian Pty Ltd. Psychoactive Substances Product Offered
Table 105. Cyrelian Pty Ltd. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Cyrelian Pty Ltd. Main Business
Table 107. Cyrelian Pty Ltd. Latest Developments
Table 108. MedReleaf Australia Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 109. MedReleaf Australia Psychoactive Substances Product Offered
Table 110. MedReleaf Australia Main Business
Table 111. MedReleaf Australia Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. MedReleaf Australia Latest Developments
Table 1. Psychoactive Substances Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Stimulants
Table 3. Major Players of Cannabinoids
Table 4. Major Players of Hallucinogens
Table 5. Major Players of Depressants
Table 6. Psychoactive Substances Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Psychoactive Substances Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Psychoactive Substances Market Size Market Share by Type (2018-2023)
Table 9. Psychoactive Substances Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Psychoactive Substances Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Psychoactive Substances Market Size Market Share by Application (2018-2023)
Table 12. Global Psychoactive Substances Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Psychoactive Substances Revenue Market Share by Player (2018-2023)
Table 14. Psychoactive Substances Key Players Head office and Products Offered
Table 15. Psychoactive Substances Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Psychoactive Substances Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Psychoactive Substances Market Size Market Share by Regions (2018-2023)
Table 20. Global Psychoactive Substances Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Psychoactive Substances Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Psychoactive Substances Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Psychoactive Substances Market Size Market Share by Country (2018-2023)
Table 24. Americas Psychoactive Substances Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Psychoactive Substances Market Size Market Share by Type (2018-2023)
Table 26. Americas Psychoactive Substances Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Psychoactive Substances Market Size Market Share by Application (2018-2023)
Table 28. APAC Psychoactive Substances Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Psychoactive Substances Market Size Market Share by Region (2018-2023)
Table 30. APAC Psychoactive Substances Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Psychoactive Substances Market Size Market Share by Type (2018-2023)
Table 32. APAC Psychoactive Substances Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Psychoactive Substances Market Size Market Share by Application (2018-2023)
Table 34. Europe Psychoactive Substances Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Psychoactive Substances Market Size Market Share by Country (2018-2023)
Table 36. Europe Psychoactive Substances Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Psychoactive Substances Market Size Market Share by Type (2018-2023)
Table 38. Europe Psychoactive Substances Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Psychoactive Substances Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Psychoactive Substances Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Psychoactive Substances Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Psychoactive Substances Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Psychoactive Substances Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Psychoactive Substances Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Psychoactive Substances Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Psychoactive Substances
Table 47. Key Market Challenges & Risks of Psychoactive Substances
Table 48. Key Industry Trends of Psychoactive Substances
Table 49. Global Psychoactive Substances Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Psychoactive Substances Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Psychoactive Substances Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Psychoactive Substances Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Zynerba Pharmaceuticals Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 54. Zynerba Pharmaceuticals Psychoactive Substances Product Offered
Table 55. Zynerba Pharmaceuticals Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Zynerba Pharmaceuticals Main Business
Table 57. Zynerba Pharmaceuticals Latest Developments
Table 58. GW Pharmaceuticals PLC. Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 59. GW Pharmaceuticals PLC. Psychoactive Substances Product Offered
Table 60. GW Pharmaceuticals PLC. Main Business
Table 61. GW Pharmaceuticals PLC. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. GW Pharmaceuticals PLC. Latest Developments
Table 63. Enecta. Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 64. Enecta. Psychoactive Substances Product Offered
Table 65. Enecta. Main Business
Table 66. Enecta. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Enecta. Latest Developments
Table 68. Teewinot Life Sciences Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 69. Teewinot Life Sciences Psychoactive Substances Product Offered
Table 70. Teewinot Life Sciences Main Business
Table 71. Teewinot Life Sciences Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Teewinot Life Sciences Latest Developments
Table 73. GD Pharma Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 74. GD Pharma Psychoactive Substances Product Offered
Table 75. GD Pharma Main Business
Table 76. GD Pharma Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. GD Pharma Latest Developments
Table 78. Cape Bouvard Technologies Pty Ltd Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 79. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Offered
Table 80. Cape Bouvard Technologies Pty Ltd Main Business
Table 81. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Cape Bouvard Technologies Pty Ltd Latest Developments
Table 83. AusCann Group Holdings Pty Ltd. Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 84. AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Offered
Table 85. AusCann Group Holdings Pty Ltd. Main Business
Table 86. AusCann Group Holdings Pty Ltd. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. AusCann Group Holdings Pty Ltd. Latest Developments
Table 88. Cannabics Pharmaceuticals Inc. Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 89. Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Offered
Table 90. Cannabics Pharmaceuticals Inc. Main Business
Table 91. Cannabics Pharmaceuticals Inc. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Cannabics Pharmaceuticals Inc. Latest Developments
Table 93. Alpha-CAT Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 94. Alpha-CAT Psychoactive Substances Product Offered
Table 95. Alpha-CAT Main Business
Table 96. Alpha-CAT Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Alpha-CAT Latest Developments
Table 98. Tilray Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 99. Tilray Psychoactive Substances Product Offered
Table 100. Tilray Main Business
Table 101. Tilray Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Tilray Latest Developments
Table 103. Cyrelian Pty Ltd. Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 104. Cyrelian Pty Ltd. Psychoactive Substances Product Offered
Table 105. Cyrelian Pty Ltd. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Cyrelian Pty Ltd. Main Business
Table 107. Cyrelian Pty Ltd. Latest Developments
Table 108. MedReleaf Australia Details, Company Type, Psychoactive Substances Area Served and Its Competitors
Table 109. MedReleaf Australia Psychoactive Substances Product Offered
Table 110. MedReleaf Australia Main Business
Table 111. MedReleaf Australia Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. MedReleaf Australia Latest Developments
LIST OF FIGURES
Figure 1. Psychoactive Substances Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psychoactive Substances Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Psychoactive Substances Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Psychoactive Substances Sales Market Share by Country/Region (2022)
Figure 8. Psychoactive Substances Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Psychoactive Substances Market Size Market Share by Type in 2022
Figure 10. Psychoactive Substances in Cancer
Figure 11. Global Psychoactive Substances Market: Cancer (2018-2023) & ($ Millions)
Figure 12. Psychoactive Substances in Neuropathic Disorders
Figure 13. Global Psychoactive Substances Market: Neuropathic Disorders (2018-2023) & ($ Millions)
Figure 14. Psychoactive Substances in Spasticity
Figure 15. Global Psychoactive Substances Market: Spasticity (2018-2023) & ($ Millions)
Figure 16. Global Psychoactive Substances Market Size Market Share by Application in 2022
Figure 17. Global Psychoactive Substances Revenue Market Share by Player in 2022
Figure 18. Global Psychoactive Substances Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Psychoactive Substances Market Size 2018-2023 ($ Millions)
Figure 20. APAC Psychoactive Substances Market Size 2018-2023 ($ Millions)
Figure 21. Europe Psychoactive Substances Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Psychoactive Substances Market Size 2018-2023 ($ Millions)
Figure 23. Americas Psychoactive Substances Value Market Share by Country in 2022
Figure 24. United States Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Psychoactive Substances Market Size Market Share by Region in 2022
Figure 29. APAC Psychoactive Substances Market Size Market Share by Type in 2022
Figure 30. APAC Psychoactive Substances Market Size Market Share by Application in 2022
Figure 31. China Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Psychoactive Substances Market Size Market Share by Country in 2022
Figure 38. Europe Psychoactive Substances Market Size Market Share by Type (2018-2023)
Figure 39. Europe Psychoactive Substances Market Size Market Share by Application (2018-2023)
Figure 40. Germany Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Psychoactive Substances Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Psychoactive Substances Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Psychoactive Substances Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 54. APAC Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 55. Europe Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 57. United States Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 58. Canada Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 61. China Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 62. Japan Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 63. Korea Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 65. India Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 66. Australia Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 67. Germany Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 68. France Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 69. UK Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 70. Italy Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 71. Russia Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 72. Spain Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 75. Israel Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 78. Global Psychoactive Substances Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Psychoactive Substances Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Psychoactive Substances Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psychoactive Substances Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Psychoactive Substances Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Psychoactive Substances Sales Market Share by Country/Region (2022)
Figure 8. Psychoactive Substances Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Psychoactive Substances Market Size Market Share by Type in 2022
Figure 10. Psychoactive Substances in Cancer
Figure 11. Global Psychoactive Substances Market: Cancer (2018-2023) & ($ Millions)
Figure 12. Psychoactive Substances in Neuropathic Disorders
Figure 13. Global Psychoactive Substances Market: Neuropathic Disorders (2018-2023) & ($ Millions)
Figure 14. Psychoactive Substances in Spasticity
Figure 15. Global Psychoactive Substances Market: Spasticity (2018-2023) & ($ Millions)
Figure 16. Global Psychoactive Substances Market Size Market Share by Application in 2022
Figure 17. Global Psychoactive Substances Revenue Market Share by Player in 2022
Figure 18. Global Psychoactive Substances Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Psychoactive Substances Market Size 2018-2023 ($ Millions)
Figure 20. APAC Psychoactive Substances Market Size 2018-2023 ($ Millions)
Figure 21. Europe Psychoactive Substances Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Psychoactive Substances Market Size 2018-2023 ($ Millions)
Figure 23. Americas Psychoactive Substances Value Market Share by Country in 2022
Figure 24. United States Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Psychoactive Substances Market Size Market Share by Region in 2022
Figure 29. APAC Psychoactive Substances Market Size Market Share by Type in 2022
Figure 30. APAC Psychoactive Substances Market Size Market Share by Application in 2022
Figure 31. China Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Psychoactive Substances Market Size Market Share by Country in 2022
Figure 38. Europe Psychoactive Substances Market Size Market Share by Type (2018-2023)
Figure 39. Europe Psychoactive Substances Market Size Market Share by Application (2018-2023)
Figure 40. Germany Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Psychoactive Substances Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Psychoactive Substances Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Psychoactive Substances Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Psychoactive Substances Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 54. APAC Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 55. Europe Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 57. United States Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 58. Canada Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 61. China Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 62. Japan Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 63. Korea Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 65. India Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 66. Australia Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 67. Germany Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 68. France Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 69. UK Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 70. Italy Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 71. Russia Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 72. Spain Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 75. Israel Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Psychoactive Substances Market Size 2024-2029 ($ Millions)
Figure 78. Global Psychoactive Substances Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Psychoactive Substances Market Size Market Share Forecast by Application (2024-2029)
